Table 1. Descriptive statistics for study sample.
Total (N=34) | p | |
---|---|---|
Age | 67.1 Â ± 9.8 (42 - 88) | 0.466 |
Female | 18 (52.9%) | 0.809 |
Arthroplasty | 0.488 | |
- Partial | 8 (23.5%) | |
- Total | 26 (76.5%) | |
Right Side | 15 (53.6%) | 0.030 |
Cementation | 0.304 | |
- Hybrid | 9 (26.5%) | |
- Non-cemented | 25 (73.5%) | |
Fracture | 15 (44.1%) | 0.063 |
Tumor Type | 0.903 | |
- Bladder | 1 (2.9%) | |
- Breast | 9 (26.5%) | |
- Gastrointestinal | 7 (20.6%) | |
- Glioblastoma | 1 (2.9%) | |
- Lung | 1 (2.9%) | |
- Lymphoma | 1 (2.9%) | |
- Melanoma | 1 (2.9%) | |
- Multiple Myeloma | 5 (14.7%) | |
- Prostate | 8 (23.5%) | |
Length Of Stay | 14.3 Â ± 24.2 (42 - 114) | 0.954 |
Death | 15 (44.1%) | 0.809 |
Time Until Death | 425.8 Â ± 388.5 (6 - 1419) | 0.019 |
Radiotherapy | 1.000 | |
- No | 30 (88.2%) | |
- Post | 2 (5.9%) | |
- Pre | 2 (5.9%) | |
Walking Time | 12.6 ± 19.1 (0 - 82) | 0.030 |
Infection | 1 (2.9%) | 0.560 |
Surgical Debridement | 1 (2.9%) | 0.560 |
Antibiotic Treatment (Ciprofloxacin/Pseudomonas) | 1 (2.9%) | 0.560 |